Bristol-Myers Squibb asked to cure high drug costs…

It’s still high season for proxies, which means we’re spending a lot of time wading through pages filled with discussions about executive compensation, board members’ qualifications to serve, the justification for perquisites, and so forth. But yesterday, we came across another shareholder resolution that reminded us of the post from a few weeks ago (the [...]...